Home  ›  Switzerland  ›  Basilea Pharmaceutica AG Allschwil

Basilea Pharmaceutica AG Allschwil insider transactions

Healthcare · SIX · Switzerland
Net insider signal · last quarter
Selling
Share price & insider trades · last quarter▲ buy   ▼ sell
CHF 58.6CHF 47.010 Apr09 Jul

Insiders were sellers over the last quarter — 5 sales, no buys — a net CHF 213K of selling. Most recent filing: 29 May 2026.

Net insider flow · last quarter
-CHF 213K0 buys · 5 sells
Insider profiles
＋●.●% avg 3m · win rate
🔒  Subscribe to access

Transactions

DateInsiderRoleTypeValue
29 May 2026ManagementSellCHF 20,800
13 May 2026ManagementSellCHF 58,617
30 Apr 2026ManagementSellCHF 21,600
Discover the latest filings, live alerts, top insiders and industry rankings →
20 Apr 2026Management▼ SellCHF 56,400
17 Apr 2026Management▼ SellCHF 56,000
26 Feb 2026Management▼ SellCHF 18,800
20 Feb 2026Management▼ SellCHF 32,807
24 Nov 2025Management▼ SellCHF 28,920
30 Sep 2025Management▼ SellCHF 56,400
21 May 2025Management▼ SellCHF 27,000
23 Apr 2025Management▼ SellCHF 57,396
23 Apr 2025Management▼ SellCHF 30,331
17 Apr 2025Management▼ SellCHF 41,256
17 Apr 2025Management▼ SellCHF 118,569
17 Apr 2025Management▼ SellCHF 173,480
Showing older filings · the 3 most recent are subscriber-only
Visit the website →

Under the EU Market Abuse Regulation (MAR), executives and board members (PDMRs) at Swiss-listed companies must disclose dealings in their company's shares to SIX. Insider Transaction Terminal aggregates these filings daily, filters out the noise and gives you the trades that actually matter.